Pictet North America Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,328
Closed -$646K 163
2018
Q3
$646K Buy
4,328
+1,781
+70% +$271K 0.09% 106
2018
Q2
$393K Hold
2,547
0.06% 109
2018
Q1
$354K Hold
2,547
0.05% 110
2017
Q4
$349K Buy
2,547
+661
+35% +$87.4K 0.05% 108
2017
Q3
$245K Hold
1,886
0.04% 123
2017
Q2
$250K Hold
1,886
0.04% 120
2017
Q1
$232K Hold
1,886
0.04% 123
2016
Q4
$208K Buy
+1,886
New +$210K 0.05% 103
2016
Q3
Sell
-3,166
Closed -$354K 110
2016
Q2
$354K Sell
3,166
-3,563
-53% -$383K 0.08% 86
2016
Q1
$677K Buy
6,729
+2,262
+51% +$217K 0.14% 66
2015
Q4
$475K Buy
4,467
+55
+1% +$5.67K 0.11% 61
2015
Q3
$411K Buy
4,412
+233
+6% +$24.1K 0.11% 61
2015
Q2
$435K Sell
4,179
-1,140
-21% -$119K 0.16% 33
2015
Q1
$576K Hold
5,319
0.11% 52
2014
Q4
$493K Buy
+5,319
New +$470K 0.1% 54
2014
Q2
Sell
-5,238
Closed -$442K 57
2014
Q1
$442K Buy
5,238
+466
+10% +$37.2K 0.12% 47
2013
Q4
$375K Buy
+4,772
New +$407K 0.08% 50

Other funds holding LH

Pictet North America Advisors's LH Position: Q4 2018 in Review

Pictet North America Advisors sold out of Labcorp (LH) in Q4 2018, closing a stake of 4,328 shares — an estimated $646K sold.

Pictet North America Advisors first reported a position in LH in Q4 2013 and held it in 17 quarters. The position peaked at $677K in Q1 2016. 742 funds tracked by Wall St. Rank hold LH as of Q4 2018.

  • Pictet North America Advisors reported no remaining Labcorp position as of Q4 2018 after selling out during the quarter.
  • Pictet North America Advisors sold 4,328 Labcorp shares in Q4 2018, an estimated $646K.
  • Pictet North America Advisors first reported a position in Labcorp in Q4 2013 and held it in 17 quarters.
  • Pictet North America Advisors's Labcorp position peaked at $677K in Q1 2016.
  • 742 funds tracked by Wall St. Rank held Labcorp as of Q4 2018.

Based on Pictet North America Advisors's 13F filing for Q4 2018, filed 31 Jan 2019.